BioVie Inc. Cash
BioVie Inc. (BIVI) had Cash of $45.75 million as of 2022-12-31, per its 10-Q filed 2023-02-10.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:Cash · last filed 2023-02-10
- 2022-12-31: Cash $45.75M.
- 2022-09-30: Cash $21.23M; Cash as first filed $24.51M.
- 2022-06-30: Cash $18.64M.
- 2022-03-31: Cash $24.51M.
| Period end | Cash | Cash as first filed |
|---|---|---|
| 2022-12-31 | $45.75M 10-Q · filed 2023-02-10 | |
| 2022-09-30 | $21.23M 10-Q · filed 2022-11-04 | $24.51M 10-Q · filed 2022-05-11 |
| 2022-06-30 | $18.64M 10-Q · filed 2023-02-10 | |
| 2022-03-31 | $24.51M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $4.51M 10-Q · filed 2022-05-11 | $30.39M 10-Q · filed 2022-02-08 |
| 2021-09-30 | $11.35M 10-Q · filed 2022-05-11 | $20.49M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $4.51M 10-K · filed 2022-09-27 | |
| 2021-03-31 | $11.35M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $37.20K 10-Q · filed 2022-05-11 | $11.88M 10-Q · filed 2021-01-29 |
| 2020-09-30 | $13.20M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $37.20K 10-Q · filed 2022-02-08 | |
| 2020-03-31 | $3.71K 10-Q · filed 2021-05-10 | |
| 2019-12-31 | $3.11K 10-Q · filed 2021-01-29 | |
| 2019-09-30 | $249.01K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $339.92K 10-K · filed 2021-08-30 | |
| 2019-05-10 | $971.61K 10-Q · filed 2019-05-10 | |
| 2019-03-31 | $971.61K 10-Q · filed 2020-05-13 | |
| 2018-12-31 | $1.63M 10-Q · filed 2020-02-13 | |
| 2018-09-30 | $2.14M 10-Q · filed 2019-11-19 | |
| 2018-06-30 | $45.80K 10-K/A · filed 2020-08-07 | |
| 2018-03-31 | $28.08K 10-Q · filed 2019-05-10 | |
| 2017-12-31 | $1.82K 10-Q · filed 2019-02-12 | |
| 2017-09-30 | $21.70K 10-Q · filed 2018-11-14 | $21.70K 10-Q · filed 2017-11-08 |
| 2017-06-30 | $5.14K 10-K · filed 2019-09-27 | $5.14K 10-K · filed 2017-08-24 |
| 2017-03-31 | $35.31K 10-Q · filed 2018-05-14 | |
| 2016-12-31 | $4.52K 10-Q · filed 2018-02-14 | |
| 2016-09-30 | $8.74K 10-Q · filed 2017-11-08 | |
| 2016-06-30 | $123.76K 10-K · filed 2018-10-05 | |
| 2016-03-31 | $233.24K 10-Q · filed 2017-05-09 | |
| 2015-12-31 | $249.56K 10-Q · filed 2017-02-07 | |
| 2015-09-30 | $265.52K 10-Q/A · filed 2017-01-19 | |
| 2015-06-30 | $267.48K 10-K · filed 2017-08-24 | |
| 2015-03-31 | $278.54K 10-Q · filed 2016-05-23 | |
| 2014-12-31 | $288.07K 10-Q · filed 2016-02-16 | |
| 2014-09-30 | $318.15K 10-Q · filed 2015-11-13 | |
| 2014-06-30 | $332.86K 10-K · filed 2016-09-28 | |
| 2014-03-31 | $345.25K 10-Q · filed 2015-05-11 | |
| 2013-12-31 | $406.83K 10-Q · filed 2015-02-05 | |
| 2013-09-30 | $445.85K 10-Q · filed 2014-11-13 | |
| 2013-06-30 | $505.70K 10-K · filed 2015-10-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |